{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:52:19Z","timestamp":1770511939631,"version":"3.49.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,13]]},"DOI":"10.18632\/oncotarget.10638","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T16:33:54Z","timestamp":1468686834000},"page":"59006-59016","source":"Crossref","is-referenced-by-count":13,"title":["VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease"],"prefix":"10.18632","volume":"7","author":[{"given":"Wei","family":"An","sequence":"first","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhopal C.","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Zutshi","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Bielecki","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin T.","family":"Goez","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Luan","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fany","family":"Iseka","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insha","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Storck","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimla","family":"Band","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Band","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA"},{"name":"Departments of Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","article-title":"Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases","volume":"1833","author":"Borgstahl","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.18632\/oncotarget.233","article-title":"Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders","volume":"2","author":"Band","year":"2011","journal-title":"Oncotarget"},{"key":"3","first-page":"7921","article-title":"Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins","volume":"6","author":"Band","year":"2012","journal-title":"Biochemistry and Analytical Biochemistry: current research"},{"key":"4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","volume":"460","author":"Takita","year":"2009","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Kropshofer","year":"2010","journal-title":"Nature genetics"},{"key":"6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-010-0920-6","article-title":"Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies","volume":"89","author":"Haferlach","year":"2010","journal-title":"Annals of Hematology"},{"key":"7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood-2009-01-198416","article-title":"Mutations in CBL occur frequently in juvenile myelomonocytic leukemia","volume":"114","author":"Issa","year":"2009","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2009-06-226340","article-title":"Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia","volume":"115","author":"Manabe","year":"2010","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1182\/blood-2008-12-194548","article-title":"Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms","volume":"113","author":"Brandts","year":"2009","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Stary","year":"2005","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11316200-000000000-00000","article-title":"Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations","volume":"12","author":"Hirano","year":"2010","journal-title":"Paediatric drugs"},{"key":"12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Shannon","year":"1996","journal-title":"Nature genetics"},{"key":"13","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder","volume":"103","author":"Shannon","year":"2004","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2004-11-4207","article-title":"Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells","volume":"106","author":"Shannon","year":"2005","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2006-09-047530","article-title":"K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem\/progenitor cells","volume":"109","author":"Braun","year":"2007","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia","volume":"12","author":"Copeland","year":"1996","journal-title":"Nature genetics"},{"key":"17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1203\/01.PDR.0000113462.98851.2E","article-title":"Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia","volume":"55","author":"Epstein","year":"2004","journal-title":"Pediatric research"},{"key":"18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","article-title":"Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations","volume":"7","author":"Neel","year":"2005","journal-title":"Cancer cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1158\/0008-5472.CAN-07-0778","article-title":"Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice","volume":"67","author":"Ren","year":"2007","journal-title":"Cancer research"},{"key":"20","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-12-190934","article-title":"E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease","volume":"114","author":"Sargin","year":"2009","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1101\/gad.1651408","article-title":"The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells","volume":"22","author":"Flavell","year":"2008","journal-title":"Genes & development"},{"key":"22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2010.09.008","article-title":"Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling","volume":"18","author":"Langdon","year":"2010","journal-title":"Cancer cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"16274","DOI":"10.1073\/pnas.1007575107","article-title":"Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells","volume":"107","author":"Band","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"24","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.18632\/oncotarget.3403","article-title":"Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy","volume":"6","author":"Band","year":"2015","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"Kioussis","year":"2003","journal-title":"European journal of immunology"},{"key":"26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1242\/dev.020131","article-title":"C-Myc in the Hematopoietic Lineage is Crucial for its Angiogenic Function in the Mouse Embryo","volume":"135","author":"Wang","year":"2008","journal-title":"Development (Cambridge, England)"},{"key":"27","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1371\/journal.pbio.0020075","article-title":"Circulation and chemotaxis of fetal hematopoietic stem cells","volume":"2","author":"Weissman","year":"2004","journal-title":"PLoS biology"},{"key":"28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Zuckerman","year":"1991","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1038\/sj.emboj.7600841","article-title":"Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion","volume":"24","author":"Langdon","year":"2005","journal-title":"The EMBO journal"},{"key":"30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00439-015-1550-9","article-title":"Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family","volume":"134","author":"Kirby","year":"2015","journal-title":"Human genetics"},{"key":"31","article-title":"Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy","author":"Oda","year":"2016","journal-title":"Journal of human genetics"},{"key":"32","first-page":"201","article-title":"Awakening dormant haematopoietic stem cells. Nature reviews","volume":"10","author":"Wilson","year":"2010","journal-title":"Immunology"},{"key":"33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Trumpp","year":"2008","journal-title":"Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.92.22.10302","article-title":"The purification and characterization of fetal liver hematopoietic stem cells","volume":"92","author":"Weissman","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wsbm.86","article-title":"Hematopoietic stem cell: self-renewal versus differentiation. Wiley interdisciplinary reviews","volume":"2","author":"Weissman","year":"2010","journal-title":"Systems biology and medicine"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T05:06:28Z","timestamp":1656824788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,16]]},"references-count":35,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,9,13]]}},"alternative-id":["10638","27449297"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10638","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,16]]}}}